MoneyWorks4Me

Genpharmasec - Quaterly Results

10 Feb 2025 Evaluate
The Sales for the quarter ended December 2024 of Rs. 83.36 millions rose by 30.56% from Rs. 63.85 millions.The company almost doubled its revenue to Rs. 11.28 millions  from Rs. 0.63 millions in the quarter ended December 2024.Operating profit for the quarter ended December 2024 rose to 18.89 millions as compared to 1.59 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 83.36 63.85 30.56 194.09 202.08 -3.95 304.06 255.16 19.16
Other Income 9.31 1.42 555.63 23.67 4.06 483.00 7.18 1.00 618.00
PBIDT 18.89 1.59 1088.05 38.12 4.03 845.91 8.78 3.58 145.25
Interest 1.06 1.25 -15.20 2.18 2.53 -13.83 3.95 0.56 605.36
PBDT 17.83 0.34 5144.12 35.94 1.50 2296.00 4.83 3.02 59.93
Depreciation 0.46 0.05 820.00 0.94 0.13 623.08 0.17 0.20 -15.00
PBT 17.37 0.29 5889.66 35.00 1.37 2454.74 4.66 2.82 65.25
TAX 6.09 -0.34 -1891.18 7.86 0.42 1771.43 4.20 -8.43 -149.82
Deferred Tax 1.77 -0.34 -620.59 3.54 0.42 742.86 4.20 -8.43 -149.82
PAT 11.28 0.63 1690.48 27.14 0.95 2756.84 0.46 11.25 -95.91
Equity 553.72 276.86 100.00 553.72 276.86 100.00 553.72 276.86 100.00
PBIDTM(%) 22.66 2.49 810.00 19.64 1.99 884.83 2.89 1.40 105.82
Peers